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Purpose: This study was conducted to explore the incidence of and risk factors for gallstone disease
(GSD) among elderly type 2 diabetic patients (aged 60 years or older) in Kinmen, Taiwan.
Methods: In 2001, a panel of specialists performed ultrasound sonography screening on 594 elderly type
2 diabetic patients who were diagnosed in 1991e1993. The screening program involved 298 elderly type
2 diabetic patients. After excluding 51 participants with prevalent GSD, 247 participants without GSD
were invited for a second round of screening in 2002. A total of 192 (77.7%) elderly participants were re-
examined.
Results: Among the 192 elderly type 2 diabetic patients who had no GSD at the ﬁrst round screening,
eight patients had developed GSD by 2002, which is an incidence of 4.17% per year [95% conﬁdence
interval (CI) ¼ 2.22e7.05% per year]. Using a stepwise Cox regression model, the waist circumference
[relative risk (RR) ¼1.07; 95%CI ¼ 1.01e1.18] and the alanine transaminase (ALT) level (RR ¼ 1.10; 95%
CI ¼ 1.05e1.16) appeared to be signiﬁcantly related to the development of GSD.
Conclusion: Elderly type 2 diabetic patients had a slightly higher annual incidence of GSD, compared to
the general population; however, the difference was not statistically signiﬁcant. A greater waist
circumference and high normal ALT levels were also associated with the development of GSD among this
screened subpopulation.
Copyright © 2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Gallstone disease (GSD) is an escalating major health problem.
To identify risk factors in a given population, epidemiologic studies
must ﬁrst deﬁne the frequency of a disease1. Some controversy
exists regarding the association between diabetes and GSD,
although population-based epidemiologic studies have demon-
strated a positive relationship between type 2 diabetes and
increased morbidity of GSD2e6. In addition, previous evidence-
based studies exploring GSD in the elderly have focused almosts of interest to declare.
in General Hospital, No. 45,
tric Emergency & Critical Care Meentirely on the outcomes of interventions such as percutaneous
cholecystostomy and endoscopic retrograde cholangiopancreatog-
raphy, or focused on the management of elderly patients from the
moment of presentation at the hospital with symptomatic biliary
disease7e10. Our previous report also showed that the prevalence of
overall GSD is higher among elderly type 2 diabetic patients than in
other general Chinese populations when using the same methods
for GSD assessment10.
Previous evidence-based studies have explored the prevalence
and associated factors of GSD among type 2 diabetic patients2,10.
However, cross-sectional study designs only reveal useful infor-
mation of disease prevalence, but reveal nothing about the inci-
dence or temporality in the study population. To determine
incidence and causal relationships between risk factors and un-
derline disease, the population needs to be re-examined after a
period of time. From the viewpoint of preventive medicine, thedicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
The attendance rate of gallstone disease screening among 247 elderly type 2 diabetic
patients in Kinmen.
Variable Eligible population Screened population Attendance rate
n n (%)
Sex
Male 106 79 74.5
Female 141 113 80.1
Age (y)
60e69 134 111 82.8
70e79 87 65 74.7
80 26 16 61.5
Total 247 192 77.7
W.-H. Chien et al.96prevention of GSD should primarily focus on risk factors responsible
for incident GSD. Exploring the incidence of and risk factors for GSD
is essential to prevent its development and prevent the cholecys-
tectomy caused by this complication, which is often insidious in
nature3. As previously mentioned, it is necessary to conduct a
population-based study that estimates the incidence of GSD. This is
partly because of the fact that more than one-half of patients with
GSD are unaware of their condition and diagnosed patients seem to
represent a select group, based on clinical investigations11. Our
previous study indicated that old age is a known risk factor for the
development of GSD3; however, the incidence and temporal rela-
tionship between the development of GSD and various risk factors
among elderly type 2 diabetics still need to be clariﬁed. Further-
more, this study explored the incidence and risk factors of GSD
amongelderly type 2 diabetics in Kinmen, Taiwan, based on a 1-year
follow-up period using real time abdominal ultrasound.
2. Materials and methods
2.1. Organization of gallstone disease screening for type 2 diabetes
Data used in this study were derived from a population-based
screening performed between January 1991 and December 1993 for
type2diabetes thatwas targeted to individuals aged30yearsorolder
inKinmen, Taiwan. Thedetailsof the studydesignandexecutionhave
beendescribed in full elsewhere12. Inbrief, the identiﬁcationof type2
diabetes was based on the 1985 World Health Organization (WHO)
deﬁnition in which type 2 diabetes was deﬁned as a fasting plasma
glucose (FPG) level of 140 mg/dL or greater or a 2-hour postload
glucose level of 200mg/dL or greater13. Patientswith ahistoryof type
2 diabetes andwho had receivedmedicationwere deﬁned as known
cases. In the GSD screening in 2001, patientswho fulﬁlled the criteria
for type 2 diabetes based on the revised WHO 1999 were also
enrolled. Additional patientswere recruitedwhohad a FPGof at least
126 mg/dL but less than 140 mg/dL during 1991e199314. Access to
personal recordswas approved so that blood samples andultrasound
sonography results could be used, and thesewere collected as part of
the standard care by the human subject review board of Cheng-Hsin
General Hospital in Taipei, Taiwan [approval number (165)98-26].
A total of 1123 type 2 diabetic patients, aged 30 years and older,
were identiﬁed, based on face-to-face interviews performed by the
Yang-Ming Crusade, a volunteer organization of well-trained
medical students of the National Yang-Ming University (Taipei,
Taiwan). After excluding patients who had migrated or died, the
remaining 858 type 2 diabetic patients formed a cohort to receive a
ﬁrst round abdominal ultrasound in 2001. Of the 594 elderly pa-
tients who responded (269 patients were 60e69 years old and 325
patients were 70 years or older), 298 (50.2%) patients agreed to
undergo screening. This included 157 (58.4%) of the patients aged
60e69 years old and 141 (43.4%) patients aged 70 years or older. All
participants provided informed consent prior to the survey. Fifty-
one of the 298 elderly type 2 diabetics were diagnosed with any
type of GSD. The overall prevalence of GSD was 17.1%, which
included a single stone (9.1%; n ¼ 27), multiple stones (4.4%;
n ¼ 13), and cholecystectomy (3.7%; n ¼ 11)10. The 247 elderly type
2 diabetic patients without GSD who were screened in 2001 were
then invited by telephone calls or invitation letters in 2002 to
receive a second round of abdominal examinations. Informed
consent was obtained from all participants prior to the GSD
screening10.
2.2. Data collection and diagnosis of gallstone disease
In this study, fasting blood samples were drawn by public health
nurses. Overnight fasting serum and plasma samples (which werepreserved with EDTA and sodium ﬂuoride) were collected and kept
frozen (20C) until analysis for the measurement of biochemistry
markers. Fasting plasma glucose concentrations were determined
by using the hexokinase-glucose-6-phosphate dehydrogenase
method with Glucose (HK) Reagent ldt (Gilford Diagnostics, Ober-
lin, OH, USA). The BMI, waist circumference, uric acid, and glycated
hemoglobin (HbA1c) data were also collected during the GSD
screening in 2001. The duration of type 2 diabetes in patients who
were previously diagnosed with the disease was conﬁrmed by the
questionnaire. In addition, the screening protocol for GSD was
performed in 2001 and 2002. Gall stone disease was diagnosed by
two specialists who used real-time abdominal ultrasound to
examine the abdominal region after the participants had fasted for
at least 8 hours. Gallstone disease was identiﬁed, based on the
presence of “movable” hyperechoic material with an acoustic
shadow. Cases of GSD were classiﬁed as follows: single gallbladder
stone, multiple gallbladder stones, and cholecystectomy (excluding
gallbladder polyps). Cases were identiﬁed as any type of GSD
among the elderly type 2 diabetics.
2.3. Interobserver reliability in ultrasound sonography
To establish a consistent diagnosis of GSD, the kappa statistic
was used to assess interobserver reliability between the two spe-
cialists. A pilot study was performed with a randomly selected
cohort of type 2 diabetic individuals (n ¼ 50) other than the study
participants. Our pilot study on interobserver reliability showed a
kappa value of 0.77 for a diagnosis of GSD [95% conﬁdence interval
(CI) ¼ 0.50e0.96]3.
2.4. Statistical analysis
Statistical analysis was performed using SAS 9.1 statistical
software (SAS Institute Inc., Cary, NC, USA). The results are pre-
sented as the mean ± the standard deviation. The incidence of GSD
per year was determined based on the ratio of the observed
number of patients to the total number of patient-years at risk.
Ninety-ﬁve percent conﬁdence intervals for incidence density were
calculated using the Poisson distribution. In univariate analysis, a t
test was applied for continuous variables. Multiple Cox’s regression
was used to investigate the independence of factors associatedwith
development of GSD. A p < 0.05 was considered statistically
signiﬁcant.
3. Results
One hundred and ninety-two of 247 elderly type 2 diabetic
patients without GSD in 2001 attended the second round of
abdominal ultrasound examinations in 2002 with a 77.7% overall
Table 2
Sex and age-speciﬁc incidence of gallstone disease among 192 elderly type 2 diabetic
patients in Kinmen, Taiwan.
Variable Incidence of any gallstone disease
No. of no GSD
at ﬁrst screening
New cases Incidence density
(% per year) (95%CI)
Sex
Male 79 1 1.27
(0.07e4.37)
Female 113 7 6.19
(2.91e10.04)
p 0.08
Age (y)
60e69 111 4 3.60
(1.12e8.37)
70e79 65 3 4.62
(2.39e10.52)
80þ 16 1 6.25
(1.44e13.32)
p 0.06
Total 192 8 4.17
(2.22e7.05)
Gallstone Disease Among Elderly Type 2 Diabetics 97attendance rate. Participants were considered “censored cases” if
their outcomes were unavailable. Table 1 shows that females had
higher attendance rates, compared to males (80.1% versus 74.5%,
respectively). Very elderly people (i.e., agedmore than 80 years old)
had a lower attendance rate than other age groups.
Table 2 shows sex and age-speciﬁc 1-year incidences of GSD. The
overall incidence of GSD was estimated at 4.17% per year (95%
CI¼ 2.22e7.05% per year). This incidence indicates a trendwith age,
but showed no statistical signiﬁcance (p ¼ 0.06); the values
increased monotonically: from 3.60% per year (95%CI ¼ 1.12%e
8.37% per year) at age 60e69 years to 4.62% per year (95%
CI ¼ 2.39%e10.52% per year) at age 70e79 years, and to 6.25% per
year (95%CI ¼ 1.44%e13.32% per year) at age 80 or more years.
There was no signiﬁcant consistent pattern by age group. Females
had an approximately ﬁve-fold higher incidence, compared to
males (6.19% per year vs. 1.27% per year, respectively; p ¼ 0.08),
although the sex difference was not statistically signiﬁcant.
Table 3 shows the risk factors for the development of GSD in
elderly type 2 diabetic patients by univariate analysis. The risk
factors that were signiﬁcantly related to the development of GSD
included age (t ¼ 3.37, p ¼ 0.03), BMI (t ¼ 7.67, p < 0.0001), waistTable 3
Univariate analysis of risk factors for the development of gallstone disease among 192 e
Variables
Yes
Mean ± SD Mean
Age (y) 76.63 ± 7.23 70.21
Duration of diabetes (y) 9.75 ± 1.44 9.44
Fasting plasma glucose (mg/dL) 148.19 ± 20.68 146.21
HbA1c (%) 8.15 ± 0.99 8.28
Systolic blood pressure (mmHg) 148.18 ± 10.77 146.79
Diastolic blood pressure (mmHg) 87.65 ± 8.19 85.41
Body mass index (kg/m2) 26.90 ± 1.00 25.17
Waist circumference (cm) 90.00 ± 7.51 86.53
Total cholesterol (mg/dL) 219.28 ± 19.66 210.75
Triglyceride (mg/dL) 167.81 ± 27.40 146.19
AST (U/L) 25.68 ± 3.88 23.86
ALT (U/L) 32.49 ± 9.09 21.84
Uric acid (mg/dL) 5.85 ± 0.99 6.07
ALT ¼ alanine transaminase; AST ¼ aspartate transaminase; HbA1c ¼ glycated hemoglobcircumference (t ¼ 8.66, p < 0.0001), total cholesterol (t ¼ 4.38,
p ¼ 0.0001), and alanine transaminase (ALT) level (t ¼ 3.28,
p ¼ 0.001).
To assess the independence of the contributions of these factors
to the development of GSD (after adjusting for confounding fac-
tors), the signiﬁcant variables from univariate analysis for GSD
were further examined using a stepwise Cox regression model.
They included age, BMI, waist circumference, total cholesterol, and
ALT. As Table 4 shows, waist circumference [relative risk (RR)¼ 1.07,
95%CI ¼ 1.01e1.18], and ALT (RR ¼ 1.10, 95%CI ¼ 1.05e1.16)
appeared to be independently related to the development of GSD.4. Discussion
4.1. Incidence and risk factors for the development of gallstone
disease
Gallstone formation is multifactorial, and includes constitu-
tional and environmental factors. People with GSD have increased
mortality, overall mortality, and mortality from cardiovascular
disease and cancer. This relationship exists for ultrasound-
diagnosed GSD and cholecystectomy15. Gallstone disease with
complications, especially cholecystitis and cholangitis, in the
elderly is associated with high morbidity and mortality rates16.
A particular strength of this studywas the incidence follow up of
the study participants, based on GSD determined by
ultrasonography.
Abdominal ultrasound for GSD screening is viewed as a robust
method. Previous clinical studies have shown reliable positive
(0.99e1.00) and negative (0.90e0.96) predictive values of ultraso-
nography diagnostic efﬁcacy17.
The annual incidence GSD of elderly type 2 diabetics in this
study was higher than in younger diabetic patients or the general
population using the same methodology of GSD assessments as in
previous studies18e20. These results implied that type 2 diabetes
may be a positive risk factor for GSD development among an elderly
population. From a pathophysiological viewpoint, GSD and diabetes
were strongly associated with an abnormal baseline glucose sta-
tus15. It is generally believed that individuals with diabetes secrete
more lithogenic bile than nondiabetics (i.e., diabetes and GSD may
be viewed as closely linked diseases)21. Patients with late-onset
diabetes have a higher lithogenic bile index than nondiabetic in-
dividuals, after adjusting for sex and age3. In addition, diabeticlderly type 2 diabetic patients in Kinmen, Taiwan.
Development of gallstone disease
No p for t test Deﬁnition of disease condition
± SD
± 6.77 0.03 d
± 1.50 0.56 d
± 42.90 0.89  126 mg/dL
± 1.60 0.82  7%
± 15.73 0.80  140 mmHg
± 10.16 0.78  90 mmHg
± 3.01 < 0.0001  27 kg/m2
± 7.74 < 0.0001  90 cm for males or
 80 cm for females
± 25.32 0.0001  200 mg/dL
± 68.72 0.07  200 mg/dL
± 9.35 0.53  40 U/L
± 8.98 0.001  40 U/L
± 1.22 0.61  7 mg/dL for males or
 6 mg/dL for females
in.
Table 4
Stepwise Cox regression model of risk factors associated with the development of
gallstone disease among 192 elderly type 2 diabetic patients in Kinmen, Taiwan.
Variablesa Development of gallstone disease (“yes” vs. “no”)
Relative risk 95% CI
Waist circumference (cm) 1.07 1.01e1.18
ALT (U/L) 1.10 1.05e1.16
ALT ¼ alanine transaminase; CI ¼ conﬁdence interval.
a Initial independent variables included all univariate signiﬁcant factors: age, BMI,
waist circumference, total cholesterol, and ALT.
W.-H. Chien et al.98patients represent cases of hyperglycemia that reﬂect relevant ef-
fects on gallbladder motility3.
In Taiwan, an epidemiologic study revealed that being older
than 60 years of age was the most important risk factor for the
development of GSD22. Long-term exposure to risk factors in an
elderly population such as the duration of type 2 diabetes also may
account for the increased probability of developing GSD22,23.
Chronic environmental factors in addition to the effect of aging
could cause cholelithiasis, although our study demonstrated that
age is not a signiﬁcant risk factor for the development of GSD, based
on multiple Cox’s regression model. This result is concordant with
results from other studies that had longer screening intervals24,25.
Large amounts of cholesterol secreted by the liver and decreased
catabolism of cholesterol to bile acid have been observed in the
elderly3,26. This implied that the pathogenesis of GSD is multifac-
torial and that it probably develops from complex interactions
among numerous genetic and environmental factors that have
increasing inﬂuence with aging27. Age remains a major factor that
leads to GSD development, irrespective of locality or standard of
living, or after adjusting for other demographic and clinical char-
acteristics in multivariate analysis3.
Obesity could raise the saturation of bile by increasing the
biliary secretion of cholesterol; the latter probably depends on a
higher synthesis of cholesterol in obese individuals28. Epidemio-
logic data concerning the relation between abdominal obesity and
GSD are sparse and controversial. We found that a higher waist
circumference was signiﬁcantly associated with a higher risk of
GSD, even after controlling for BMI. A possible reason that the
absence of an independent association between BMI and
GSDdafter controlling for waist circumference (which was a sig-
niﬁcant predictor)dwas because of the high correlation between
BMI and waist circumference (r ¼ 0.71) in the elderly type 2 dia-
betes study population. From a biological perspective, the variation
in BMI attributable to adiposity is essentially controlled by the
waist circumference variable; therefore, the BMI becomes primarily
a surrogate of lean body mass when the BMI and waist circumfer-
ence are included in the same model19. In addition, central fat
distribution may be a more predictive risk factor for GSD than is
overall obesity.
Cirrhosis is a well-established risk factor for GSD, particularly in
its more advanced stages1,3,29. The annual incidence of GSD in pa-
tients with cirrhosis appears to be approximately eight times
higher than in the general population24. However, based on the
population-based study design, the participants in this study are
relatively healthier than clinical patients. It is difﬁcult to explore
the association between liver cirrhosis, hemolytic anemia, uremia,
and GSD because very few patients were diagnosed. Determining
the serum ALT levels currently constitutes the most frequently
applied test for identifying patients who have liver disease10. Our
results showing that a high normal ALT level constitutes a higher
risk of developing GSD suggests that appropriate integrated diag-
nosis and therapy in the early stage of liver dysfunction mayeventually enable the prevention of incident GSD among elderly
type 2 diabetic patients. Instead of being a sign of more serious liver
disease such as liver cirrhosis, further long-term studies should be
conducted to explore the possibility that high normal ALT levels is
an indicator for GSD among elderly type 2 diabetic patients because
it indicates a fatty liver and early stage of chronic liver disease.
4.2. Methodological considerations
There are some limitations in this study, although using a
follow-up study design could clarify the temporal relationship of
potential risk factors for the development of GSD among elderly
type 2 diabetic population. First, except for age, the characteristics
pertinent to the risk of GSD in elderly type 2 diabetic patients were
not signiﬁcantly different from the nonresponders, which implies
that participants who did not return for follow up may have a more
severe stage of GSD. Second, we assumed that all new GSD cases
occurred at the 2002 screening time point. Because additional GSD
cases could have occurred in subsequent years, the incidence of
GSD may be underestimated. Third, there were no elderly partici-
pantswithout type 2 diabetes in the study population; therefore, an
evaluation of the extent of incident GSD in nontype 2 diabetes is
difﬁcult. Fourth, our analysis only focused on clinically relevant
GSD because we did not estimate the incidence of gallstone for-
mation but rather the incidence of newly screened GSD. Fourth, the
relatively small sample size allowed us to estimate the “true” ef-
fects between the potential risk factors. The incidence of GSD is also
difﬁcult to determine because of the shorter follow-up period.
Further long-term studies are needed to explore the morbidity of
elderly GSD and plausible biological mechanisms underlying its
development.
5. Conclusion
The elderly type 2 diabetic patients had a slightly higher annual
incidence of GSD, compared to the general population, but this
difference was not statistically signiﬁcant. A greater waist circum-
ference and high normal ALT levels are also associated with the
development of GSD among this screened subpopulation.
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